A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei.
Saunders, Mark P
Wilson, Malcolm S
O'Dwyer, Sarah T
Stern, Peter L
Renehan, Andrew G
AffiliationCancer Research UK Immunology Group, Paterson Institute for Cancer Research, Manchester, UK.
MetadataShow full item record
AbstractPseudomyxoma peritonei (PMP) is a rare neoplasm of mainly appendiceal origin, characterised by excess intra-abdominal mucin production leading to high morbidity and mortality. While histological features are frequently indolent, this tumour disseminates aggressively throughout the abdominal cavity, yet seldom metastasises. This study determined the expression of several markers of colorectal differentiation (carcinoembryonic antigen (CEA), cytokeratins (CK20 and CK7), epithelial membrane antigen), mucin production (MUC-2, interleukin-9 (IL-9), IL-9 receptor (IL-9Ralpha)), and cell adhesion (N- and E-cadherin, vimentin) in PMP tissue (n=26) compared with expressions in normal colonic mucosa (n=19) and colorectal adenocarcinoma (n=26). Expressions of CEA and cytokeratins were similar for PMP as those in colorectal adenocarcinomas with the exception that the CK20-/CK7- pattern was rare in PMP (Fisher's exact test: P=0.001). Similarly, expressions of mucin-related proteins were comparable for adenocarcinoma and PMP, with the exception that IL-9 expression was uncommon in adenocarcinoma (P=0.009). Pseudomyxoma peritonei demonstrated a specific pattern of adhesion-related protein expressions of increased N-cadherin, reduced E-cadherin, and increased vimentin (P=0.004), a phenotype suggesting a possible epithelial-mesenchymal transition state. Primary PMP cell cultures were successfully maintained and demonstrated marker expressions similar to those seen in in vivo tissues. These early characterisation studies demonstrate similarities between PMP and colorectal adenocarcinoma, but also reveal a specific cadherin phenotype that may characterise the distinct non-metastasising behaviour of PMP, and form the basis for future mechanistic and therapy-targeting research.
CitationA specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. 2006, 95 (9):1258-64 Br. J. Cancer
JournalBritish Journal of Cancer
- CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases.
- Authors: Nonaka D, Kusamura S, Baratti D, Casali P, Younan R, Deraco M
- Issue date: 2006 Oct
- Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
- Authors: McKenney JK, Soslow RA, Longacre TA
- Issue date: 2008 May
- Histological origin of pseudomyxoma peritonei in Chinese women: clinicopathology and immunohistochemistry.
- Authors: Guo AT, Song X, Wei LX, Zhao P
- Issue date: 2011 Aug 14
- MUC2 is a molecular marker for pseudomyxoma peritonei.
- Authors: O'Connell JT, Hacker CM, Barsky SH
- Issue date: 2002 Sep
- Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients.
- Authors: Jackson SL, Fleming RA, Loggie BW, Geisinger KR
- Issue date: 2001 Jul